Detalhe da pesquisa
1.
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.
J Infect Dis
; 207(8): 1216-20, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23315324
2.
Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?
J Infect Dis
; 205(4): 540-7, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22279171
3.
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
Clin Infect Dis
; 54(9): 1364-72, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22460971
4.
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.
J Antimicrob Chemother
; 67(4): 995-1000, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22258921
5.
Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women.
BMC Med Res Methodol
; 12: 110, 2012 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22839414
6.
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
Ann Intern Med
; 154(8): 509-15, 2011 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21502648
7.
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.
J Antimicrob Chemother
; 66(8): 1886-96, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21624929
8.
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.
Eur J Neurol
; 18(3): 527-34, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21159073
9.
Factors influencing lopinavir and atazanavir plasma concentration.
J Antimicrob Chemother
; 65(1): 129-37, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19897506
10.
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.
Haematologica
; 94(6): 875-80, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19336735
11.
Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication.
Antivir Ther
; 13(5): 675-85, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18771051
12.
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study.
Lancet
; 370(9603): 1923-8, 2007 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18068516
13.
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures.
AIDS
; 21(11): 1423-30, 2007 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-17589188
14.
Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backbone.
Antivir Ther
; 18(2): 213-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23653911
15.
Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care.
AIDS
; 27(1): 95-103, 2013 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22713479
16.
Biomarkers to monitor safety in people on art and risk of mortality.
J Acquir Immune Defic Syndr
; 60(1): 51-8, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22330610
17.
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study.
PLoS One
; 7(11): e49314, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23145150
18.
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
AIDS
; 26(13): 1691-705, 2012 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22546987
19.
The impact of HIV drug resistance testing on changes to treatment.
AIDS
; 25(5): 603-10, 2011 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21297420
20.
Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception.
AIDS
; 25(13): 1647-55, 2011 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673558